Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Research and development | 1.3 | 0.5 | 0.1 |
| General and administrative | 2.1 | 1.1 | 0.8 |
| EBIT | -3.4 | -1.6 | -0.9 |
| Pre-tax income | -3.4 | -1.6 | -0.8 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -4.0 | -2.2 | -1.1 |
| |
| Diluted EPS | ($1.26) | ($0.67) | ($0.34) |
| Shares outstanding (diluted) | 3.2 | 3.2 | 3.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|